Sorry for the common question on this forum but I'm new to NGS and hoping to get advise on the best platform to use to monitor bacterial resistance to therapy. We will have a reference strain but will want to compare subsequent isolates to the reference sequence. Any help would be much appreciated.
-
-
If you are looking for a relatively inexpensive solution then some form of Illumina sequencing (HiSeq/MiSeq) would be hard to beat.
If you need to compare "near finished" genomes then including PacBio (at least for the reference strain) would be advisable. Unless your "reference" strain is available in a finished form, then PacBio may not be needed.Last edited by GenoMax; 12-04-2013, 12:22 PM.
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...Today, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM
Comment